-
1دورية أكاديمية
المؤلفون: Lo mauro A., Aliverti A.
المساهمون: Lo mauro, A., Aliverti, A.
مصطلحات موضوعية: Biological drugs, Neuroprotective drugs, Pharmacology, Secondary brain damage, Traumatic brain injury, Female, Humans, Lung, Male, Sex Factors, Exercise, Respiration
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34750114; info:eu-repo/semantics/altIdentifier/wos/WOS:000769745400005; volume:30; issue:162; firstpage:1; lastpage:16; numberofpages:16; journal:EUROPEAN RESPIRATORY REVIEW; http://hdl.handle.net/11311/1206763Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85121583337
-
2
المؤلفون: Antonella LoMauro, Andrea Aliverti
المصدر: European Respiratory Review, Vol 30, Iss 162 (2021)
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Breathing control, Male, Secondary brain damage, Respiratory physiology, Diseases of the respiratory system, Traumatic brain injury, Sex Factors, Neuroprotective drugs, medicine, Humans, Biological drugs, Lung, Exercise, Pharmacology, Biological variable, RC705-779, business.industry, Respiration, Transsexual, Clinical research, medicine.anatomical_structure, Homogeneous, Female, business, Clinical psychology, Hormone
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecf4854640509c7f7f27e551e843f638Test
http://err.ersjournals.com/content/30/162/210038.fullTest -
3
المؤلفون: Dionisio Silvaggio, Colin Gerard Egan, Paul Lombardo, Marco Galluzzo, A. Massaro, Mark S. Talamonti, S D'Adamio, Luca Bianchi
المصدر: Expert Opinion on Biological Therapy. 20:95-104
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Moderate to severe, medicine.medical_specialty, Treatment response, HLA-C*06, Clinical Biochemistry, Logistic regression, Severity of Illness Index, ustekinumab, 03 medical and health sciences, 0302 clinical medicine, drug survival, Internal medicine, Psoriasis, Drug Discovery, Ustekinumab, medicine, Humans, Aged, PASI, biological drugs, Pharmacology, Plaque psoriasis, Settore MED/35 - Malattie Cutanee e Veneree, Cumulative toxicity, business.industry, Middle Aged, Retention rate, medicine.disease, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Dermatologic Agents, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b6fca55bd86a6f9dc91db2102c3f208Test
https://doi.org/10.1080/14712598.2020.1684472Test -
4
المؤلفون: Stig Andersen, Thomas Bo Jensen, Hanne Rolighed Christensen, Dorthe Bartels, Mette Marie Hougaard Christensen, Eva Aggerholm Sædder, Lars Peter Nielsen, Birgitte Klindt Poulsen
المصدر: Jensen, T B, Bartels, D, Sædder, E A, Poulsen, B K, Andersen, S E, Christensen, M M H, Nielsen, L & Christensen, H R 2020, ' The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars ', European Journal of Clinical Pharmacology, vol. 76, no. 1, pp. 35–40 . https://doi.org/10.1007/s00228-019-02765-3Test
Jensen, T B, Bartels, D, Sædder, E A, Poulsen, B K, Andersen, S E, Christensen, M M H, Nielsen, L & Christensen, H R 2020, ' The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars ', European Journal of Clinical Pharmacology, vol. 76, no. 1, pp. 35-40 . https://doi.org/10.1007/s00228-019-02765-3Testمصطلحات موضوعية: Male, medicine.medical_specialty, Denmark, medicine.medical_treatment, Pharmacology toxicology, Anti-TNF drugs, 030226 pharmacology & pharmacy, Drug Costs, Etanercept, Danish, Biological drugs, 03 medical and health sciences, Pharmacoeconomics, 0302 clinical medicine, Cost Savings, medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Intensive care medicine, Biosimilar Pharmaceuticals, Pharmacology, Biosimilars, business.industry, Biosimilar, General Medicine, Infliximab, language.human_language, TNF inhibitor, language, Female, Tumor Necrosis Factor Inhibitors, Non-medical shift, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cafd9a0788c1ad2f93650d75928bf814Test
https://vbn.aau.dk/da/publications/253195a6-4e8a-4934-ad4f-d6895a914a7bTest -
5Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases
المؤلفون: Piercarlo Sarzi-Puttini, Simone Saibeni, Savino Bruno, Cristina Bezzio, Simona Bollani, Sandro Ardizzone, Sergio Malandrin, Rossella Talotta, Piero Luigi Almasio, Paolo Declich, Fabiola Atzeni, Caterina Defendenti, Zoe Sarno, Raffaele Salerno
المساهمون: Defendenti, Caterina, Atzeni, Fabiola, Malandrin, Sergio, Ardizzone, Sandro, Almasio P.L., Saibeni, Simone, Bezzio, Cristina, Bollani, Simona, Salerno, Raffaele, Declich, Paolo, Sarno, Zoe, Bruno, Savino, Talotta, Rossella, Sarzi-Puttini, Piercarlo
المصدر: International Immunopharmacology. 54:329-335
مصطلحات موضوعية: Male, 0301 basic medicine, T-Lymphocytes, Immunophenotyping, B cell homeostasis, Biological drugs, Inflammatory bowel diseases, Plasmablasts, TNF-α, Homeostasis, Immunology and Allergy, CD20, B-Lymphocytes, biology, B-Lymphocyte, Antibodies, Monoclonal, Middle Aged, Flow Cytometry, medicine.anatomical_structure, Female, Tumor necrosis factor alpha, Immunotherapy, Antibody, Human, Adult, Adolescent, Biological drug, Immunology, B-Lymphocyte Subsets, Plasmablast, CD19, Young Adult, 03 medical and health sciences, Homeostasi, medicine, Humans, B cell, B-Lymphocyte Subset, Pharmacology, Tumor Necrosis Factor-alpha, business.industry, Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 030104 developmental biology, T-Lymphocyte, biology.protein, Bone marrow, business, CD27 Ligand
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa6d07de10b12e809ed20488dd80937Test
https://doi.org/10.1016/j.intimp.2017.11.016Test -
6
المؤلفون: Louis Jacob, Karel Kostev, Anna Bauer
المصدر: International journal of clinical pharmacology and therapeutics. 57(4)
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Index date, Adolescent, MEDLINE, Dermatology, Gastroenterology, Biological drugs, Young Adult, Primary outcome, Rheumatology, Internal medicine, Germany, medicine, Humans, Pharmacology (medical), In patient, Young adult, Pharmacology, Biological Products, business.industry, Mean age, Middle Aged, Female, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b95a573b12ac821d58ac984c636f918Test
https://pubmed.ncbi.nlm.nih.gov/30738498Test -
7
المؤلفون: Carmen D'Amore, Mariangela Rossi, Roberto Da Cas, Giuseppe Traversa
المصدر: Biodrugs
مصطلحات موضوعية: Male, Time Factors, Pharmacology, Biological drugs, 03 medical and health sciences, 0302 clinical medicine, Biosimilar Pharmaceuticals, Medicine, Humans, Pharmacology (medical), 030212 general & internal medicine, Original Research Article, Erythropoietin, Aged, Retrospective Studies, 030203 arthritis & rheumatology, Aged, 80 and over, business.industry, Drug Substitution, Biosimilar, General Medicine, Risk analysis (engineering), Italy, Hematinics, Female, business, Biotechnology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24509ef97330ef84eac673887639fc69Test
https://pubmed.ncbi.nlm.nih.gov/26728875Test -
8
المؤلفون: Paul Baldrick
المصدر: Regulatory Toxicology and Pharmacology. 59:227-236
مصطلحات موضوعية: Male, Research design, Drug, medicine.medical_specialty, Maximum Tolerated Dose, media_common.quotation_subject, Drug Evaluation, Preclinical, Immunoglobulins, Biology, Pharmacology, Toxicology, Toxicology studies, Biological drugs, Clinical investigation, Toxicity Tests, medicine, Animals, Intensive care medicine, Human proteins, media_common, Clinical study design, Antibodies, Monoclonal, General Medicine, Macaca mulatta, Repeat dose, Recombinant Proteins, Macaca fascicularis, Research Design, Models, Animal, Female
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1d7e93d61617d28bbabaf2aa55952b9Test
https://doi.org/10.1016/j.yrtph.2010.10.005Test -
9
المؤلفون: Silvo Koder, Ivan Ferkolj, Cvetka Pernat, Katja Repnik, Uroš Potočnik, Pavel Skok, Rinse K. Weersma
المساهمون: Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI)
المصدر: Pharmacogenomics, 16(3), 191-204. FUTURE MEDICINE LTD
مصطلحات موضوعية: Adult, Genetic Markers, Male, Candidate gene, Genotype, SUSCEPTIBILITY LOCI, EXTRAINTESTINAL MANIFESTATIONS, Slovenia, Autophagy-Related Proteins, Genome-wide association study, Single-nucleotide polymorphism, Inflammatory bowel disease, Polymorphism, Single Nucleotide, Crohn Disease, single nucleotide polymorphism, MODULATES EXPRESSION, adalimumab, Genetics, medicine, Adalimumab, SNP, Humans, GENOME-WIDE ASSOCIATION, ATG16L1, Genetic Association Studies, Pharmacology, pharmacogenomics, business.industry, Tumor Necrosis Factor-alpha, MELTING CURVE ANALYSIS, Middle Aged, medicine.disease, INFLIXIMAB THERAPY, Crohn's disease, RECEPTOR GENE, C-Reactive Protein, Treatment Outcome, CLINICAL REMISSION, ULCERATIVE-COLITIS, Pharmacogenomics, Immunology, Molecular Medicine, Female, business, Carrier Proteins, medicine.drug, biological drugs, INFLAMMATORY-BOWEL-DISEASE
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad2c42cbc263cb85c11513d0b5310fcdTest
https://research.rug.nl/en/publications/10ba2095-f84c-4aa0-a1a0-44ed68279c19Test